1. Home
  2. Labeler Index
  3. Tetraphase Pharmaceuticals, Inc.
  4. 71773-100
  5. NDC Package Code: 71773-100-12 Xerava

NDC Package 71773-100-12 Xerava

Eravacycline Injection, Powder, Lyophilized, For Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
71773-100-12
Package Description:
12 CARTON in 1 PACKAGE / 1 VIAL, GLASS in 1 CARTON (71773-100-05) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS
Product Code:
71773-100
Proprietary Name:
Xerava
Non-Proprietary Name:
Eravacycline
Substance Name:
Eravacycline Dihydrochloride
Usage Information:
Eravacycline is used to treat certain abdominal infections (such as appendicitis, diverticulitis, gastric/intestinal perforation). This medication belongs to a class of drugs known as tetracycline antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.
11-Digit NDC Billing Format:
71773010012
NDC to RxNorm Crosswalk:
  • RxCUI: 2055911 - eravacycline 50 MG Injection
  • RxCUI: 2055911 - eravacycline 50 MG (equivalent to eravacycline dihydrochloride 63.5 MG) Injection
  • RxCUI: 2055916 - XERAVA 50 MG Injection
  • RxCUI: 2055916 - eravacycline 50 MG Injection [Xerava]
  • RxCUI: 2055916 - Xerava 50 MG Injection
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Tetraphase Pharmaceuticals, Inc.
    Dosage Form:
    Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • ERAVACYCLINE DIHYDROCHLORIDE 100 mg/1
    • Pharmacologic Class(es):
  • Tetracycline-class Antibacterial - [EPC] (Established Pharmacologic Class)
  • Tetracyclines - [CS]
    • Sample Package:
    No
    FDA Application Number:
    NDA211109
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    09-10-2018
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 71773-100-12 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    71773010012J0122Inj., eravacycline, 1 mg1 MG1121001200

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 71773-100-12?

    The NDC Packaged Code 71773-100-12 is assigned to a package of 12 carton in 1 package / 1 vial, glass in 1 carton (71773-100-05) / 1 injection, powder, lyophilized, for solution in 1 vial, glass of Xerava, a human prescription drug labeled by Tetraphase Pharmaceuticals, Inc.. The product's dosage form is injection, powder, lyophilized, for solution and is administered via intravenous form.

    Is NDC 71773-100 included in the NDC Directory?

    Yes, Xerava with product code 71773-100 is active and included in the NDC Directory. The product was first marketed by Tetraphase Pharmaceuticals, Inc. on September 10, 2018 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 71773-100-12?

    The 11-digit format is 71773010012. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-271773-100-125-4-271773-0100-12